Literature DB >> 10598974

"Optimum" formulae for heart rate correction of the QT interval.

K Hnatkova1, M Malik.   

Abstract

The study investigated the performance of several generic QT/RR regression models in a dataset of QT and RR intervals obtained from resting electrocardiograms of 1,100 healthy subjects (913 male, mean age 33+/-12 years). All the investigated models have three degrees of freedom and included the hyperparabolic and hyper-hyperbolic models, algorithmic models, negative exponential models, and models involving inverse tangent, hyperbolic tangent, and inverse hyperbolic sign functions. For each generic model, the combination of parameters leading to the lowest regression residuum was found. The results of the study show that the goodness of the optimum fit is practically independent of the generic form of the regression model and that different datasets lead to different combinations of the numerical values of parameters of the corresponding regression models. The study concludes that the search for a universally applicable QT/RR regression model that would provide the best fit in all circumstances is most likely fruitless. Rather, individual studies such as those investigating drug related QT prolongation might benefit from establishing a best-fit regression that would provide the optimum model for each particular dataset.

Entities:  

Mesh:

Year:  1999        PMID: 10598974     DOI: 10.1111/j.1540-8159.1999.tb00390.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  22 in total

1.  Lack of correlation between exercise and sibenadet-induced changes in heart rate corrected measurement of the QT interval.

Authors:  Paul Newbold; Nick Sanders; Stots B Reele
Journal:  Br J Clin Pharmacol       Date:  2006-09-12       Impact factor: 4.335

2.  ECG evaluation of ventricular properties: the importance of cardiac cycle length.

Authors:  Fabrice Extramiana; Antoine Leenhardt; Pierre Maison-Blanche
Journal:  Ann Noninvasive Electrocardiol       Date:  2009-01       Impact factor: 1.468

Review 3.  Update on the evaluation of a new drug for effects on cardiac repolarization in humans: issues in early drug development.

Authors:  Vaibhav Salvi; Dilip R Karnad; Gopi Krishna Panicker; Snehal Kothari
Journal:  Br J Pharmacol       Date:  2009-09-23       Impact factor: 8.739

Review 4.  Evaluation of drug-induced QT interval prolongation: implications for drug approval and labelling.

Authors:  M Malik; A J Camm
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

5.  Elevated Plasma Moxifloxacin Concentrations and SLCO1B1 g.-11187G>A Polymorphism in Adults with Pulmonary Tuberculosis.

Authors:  Marc Weiner; Jon Gelfond; Teresa L Johnson-Pais; Melissa Engle; Charles A Peloquin; John L Johnson; Erin E Sizemore; William R Mac Kenzie
Journal:  Antimicrob Agents Chemother       Date:  2018-04-26       Impact factor: 5.191

6.  Individual QT-R-R relationship: average stability over time does not rule out an individual residual variability: implication for the assessment of drug effect on the QT interval.

Authors:  Fabrice Extramiana; Pierre Maison-Blanche; Fabio Badilini; Philippe Beaufils; Antoine Leenhardt
Journal:  Ann Noninvasive Electrocardiol       Date:  2005-04       Impact factor: 1.468

7.  Abnormalities of the repolarization characteristics of patients with heart failure progress with symptom severity.

Authors:  Christopher C E Lang; James M M Neilson; Andrew D Flapan
Journal:  Ann Noninvasive Electrocardiol       Date:  2004-07       Impact factor: 1.468

Review 8.  Congenital long-QT syndromes: a clinical and genetic update from infancy through adulthood.

Authors:  Gregory Webster; Charles I Berul
Journal:  Trends Cardiovasc Med       Date:  2008-08       Impact factor: 6.677

Review 9.  QT prolongation with antimicrobial agents: understanding the significance.

Authors:  Robert C Owens
Journal:  Drugs       Date:  2004       Impact factor: 9.546

10.  Intoxication after extreme oral overdose of quetiapine to attempt suicide: pharmacological concerns of side effects.

Authors:  C Müller; H Reuter; C Dohmen
Journal:  Case Rep Med       Date:  2010-01-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.